Novavax NVAX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 85%-2.5pp | 93.5%+23.2pp | 91.8%+28.0pp | 88.3%+24.6pp | 87.4%+24.5pp | |
| Operating margin | -13.1%-45.9pp | 40.3%+76.8pp | 28.9%+62.9pp | 32.6%+62.3pp | 32.8%+72.8pp | |
| Net margin | -14.7%-52.9pp | 39.2%+66.7pp | 32.1%+64.3pp | 39.2%+69.0pp | 38.1%+78.2pp | |
| EBITDA margin | -9.4%-45.7pp | 42.8%+72.1pp | 32.2%+60.9pp | 36.4%+61.5pp | 36.3%+71.9pp | |
| Returns | ||||||
| Return on assets | -7.5%-43.7pp | 32.2%+43.3pp | 23.6%+40.5pp | 26.8%+43.6pp | 36.2%+63.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×-0.4× | 0.8×+0.4× | 0.7×+0.2× | 0.7×+0.1× | 0.9×+0.3× | |
| Inventory turnover | 8.3×-3.9× | 7.2×-0.8× | 7.9×-0.3× | 13.1×-8.9× | 12.1×-2.7× | |
| Liquidity | ||||||
| Current ratio | 2.5×+0.4× | 2.1×+1.1× | 2.3×+1.3× | 2.4×+1.3× | 2.1×+1.2× | |
| Quick ratio | 2.5×+0.4× | 2.1×+1.1× | 2.2×+1.3× | 2.3×+1.3× | 2×+1.1× | |
| Cash ratio | 0.7×0.0× | 0.5×+0.1× | 0.6×+0.1× | 0.7×+0.1× | 0.6×0.0× | |
| Leverage | ||||||
| Debt-to-assets | 0.3×+0.2× | 0.2×+0.2× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Interest coverage | -3.6×-22.6× | 20.1×+32.5× | 12.6×+30.8× | 15.2×+34.5× | 19×+47.0× | |
| Per Share | ||||||
| Book value per share | -$0.89-108% | -$0.74+82.0% | -$0.97+70.7% | $0.21+108% | -$0.43+93.1% | |
| Valuation | ||||||
| Market capitalization | $1.46B+41.0% | $1.09B-15.2% | $1.41B-30.4% | $1.05B-43.6% | $1.03B+54.1% | |
| Enterprise value | $1.53B+83.6% | $1.13B+31.9% | $1.15B-24.1% | $855.37M-31.5% | $826.21M+231% | |
| Price / sales | 2.5×+1.6× | 1×-0.9× | 1.3×-1.0× | 1×-0.9× | 0.8×+0.2× | |
| EV / sales | 2.6×+1.9× | 1×-0.3× | 1.1×-0.6× | 0.8×-0.5× | 0.7×+0.4× | |
| Earnings yield | -6%-52.1pp | 40.3%+54.9pp | 24.3%+38.4pp | 40.2%+56.0pp | 46.4%+106pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Novavax's profit margins?
- Novavax (NVAX) runs a 85.0% gross margin and a -13.1% operating margin, with a -14.7% net margin.
- Where do Novavax's ratios come from?
- Every ratio is computed from Novavax's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
